Product NDC: | 0121-0581 |
Proprietary Name: | Haloperidol |
Non Proprietary Name: | Haloperidol |
Active Ingredient(s): | 2 mg/mL & nbsp; Haloperidol |
Administration Route(s): | ORAL |
Dosage Form(s): | SOLUTION, CONCENTRATE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0121-0581 |
Labeler Name: | Pharmaceutical Associates, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA073037 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091110 |
Package NDC: | 0121-0581-04 |
Package Description: | 120 mL in 1 BOTTLE (0121-0581-04) |
NDC Code | 0121-0581-04 |
Proprietary Name | Haloperidol |
Package Description | 120 mL in 1 BOTTLE (0121-0581-04) |
Product NDC | 0121-0581 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Haloperidol |
Dosage Form Name | SOLUTION, CONCENTRATE |
Route Name | ORAL |
Start Marketing Date | 20091110 |
Marketing Category Name | ANDA |
Labeler Name | Pharmaceutical Associates, Inc. |
Substance Name | HALOPERIDOL |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Typical Antipsychotic [EPC] |